Skip to main content
Fig. 7 | Orphanet Journal of Rare Diseases

Fig. 7

From: Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: a nationwide registry study in Japan

Fig. 7

Changes in HAM-BDSS by mirabegron. A-C Mean (SD) HAM-BDSS total and subscores at the third- and fourth-year interviews in patients who did and did not initiate mirabegron in the fourth year (with mirabegron, n = 7; without mirabegron, n = 115). Changes within groups were evaluated using paired t-test. HAM-BDSS, HAM/TSP-bladder dysfunction symptom score

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172